Brief: Monte Rosa Therapeutics Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
07/01/2026 21:28
Jan 7 (Reuters) - Monte Rosa Therapeutics Inc GLUE.O: MONTE ROSA THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS MONTE ROSA THERAPEUTICS INC - ANNOUNCES $200 MILLION PUBLIC OFFERING OF COMMON STOCK Source text: ID:nGNXLYlS4 Further company coverage: GLUE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Monte Rosa Therapeutics
See all newsBrief: Monte Rosa Therapeutics Announces Positive Results For Mrt-8102 In Gforce-1 Phase 1 Study Showing Normalization Of Key Pathogenic Drivers Of Ascvd In Subjects With Elevated Cvd Risk
Brief: Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Monte Rosa Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Monte Rosa Therapeutics Q2 revenue drops, net loss widens on higher R&D
Brief: Monte Rosa Therapeutics Q2 Collaboration Revenue USD 8.968 Million